Insider Trading - Nicolette Charles A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Nicolette Charles A.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-01-10
Sale(A)
2018-01-12
3:17 pm
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
CSO and Vice President of R & D
100,250 $0.1646 $16,501 399,990
(Direct)
View
2018-01-09
Sale
2018-01-12
1:55 pm
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
CSO and Vice President of R & D
100,250 $0.1646 $16,501 399,990
(Direct)
View
2018-01-03
Sale
2018-01-05
12:04 pm
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
CSO and Vice President of R & D
92,001 $0.1637 $15,061 500,240
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-04-25
Disposition
2018-04-25
4:57 pm
N/A
N/A
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
CSO and Vice President of R & D
27,150 $0 20,056
(Direct)
View
2018-03-28
Option Award
2018-03-30
5:13 pm
N/A
N/A
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
CSO and Vice President of R & D
27,150 $0 47,206
(Direct)
View
2017-08-30
Option Award
2017-08-31
6:48 pm
N/A
N/A
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
Chief Science Officer
499,445 $0 592,241
(Direct)
View
2017-01-19
Option Award
2017-01-23
3:03 pm
N/A
2027-01-18
ARGOS THERAPEUTICS INC ARGS Nicolette Charles A.
Chief Science Officer
201,753 $0 277,796
(Direct)
View
(A) Indicate amendment filing.